Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials ; day:20 ; month:12 ; year:2023 ; pages:1-14
Neurological sciences ; (20.12.2023), 1-14
- Urheber
-
Schilke, Edoardo Dalmato
Remoli, Giulia
Funelli, Eugenio
Galimberti, Michela
Fusco, Maria Letizia
Cereda, Diletta
Balducci, Claudia
Frigo, Maura
Cavaletti, Guido
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-023-07228-3
- URN
-
urn:nbn:de:101:1-2024030609151476289154
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schilke, Edoardo Dalmato
- Remoli, Giulia
- Funelli, Eugenio
- Galimberti, Michela
- Fusco, Maria Letizia
- Cereda, Diletta
- Balducci, Claudia
- Frigo, Maura
- Cavaletti, Guido
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Overview of Ongoing Clinical Trials on Radioembolization
Effect sizes in ongoing randomized controlled critical care trials
Molecular biomarkers in multiple sclerosis
Inadequate description of educational interventions in ongoing randomized controlled trials
Recent pharmacological advances on genistein in clinical trials
A systematic review of ongoing clinical trials in optic pathway gliomas
Changes to aspects of ongoing randomised controlled trials with fixed designs
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Overview of Ongoing Clinical Trials on Radioembolization
Effect sizes in ongoing randomized controlled critical care trials
Molecular biomarkers in multiple sclerosis
Inadequate description of educational interventions in ongoing randomized controlled trials
Recent pharmacological advances on genistein in clinical trials
A systematic review of ongoing clinical trials in optic pathway gliomas
Changes to aspects of ongoing randomised controlled trials with fixed designs
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Overview of Ongoing Clinical Trials on Radioembolization
Effect sizes in ongoing randomized controlled critical care trials
Molecular biomarkers in multiple sclerosis
Inadequate description of educational interventions in ongoing randomized controlled trials
Recent pharmacological advances on genistein in clinical trials
A systematic review of ongoing clinical trials in optic pathway gliomas
Changes to aspects of ongoing randomised controlled trials with fixed designs
Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Acute Myeloid Leukemia – Ongoing Trials
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions